Myeloma Canada Aurelia Initiative: Funding Myeloma Research
Honouring Innovation. Driving Research. Improving Lives.
Through Aurelia, Myeloma Canada connects research leaders, scientists, and healthcare providers. Their shared work, guided by patient priorities, supports innovative research and collaboration, helping ensure progress reaches patients in meaningful ways.
Aurelia, meaning gold and light, embodies a visionary approach to science and research – one that guides funding and reflects a commitment towards a life uninterrupted by myeloma.
Aurelia drives progress by:
- Funding promising and innovative research projects
- Advancing science and knowledge transfer to ensure research findings are disseminated, adopted, and applied across all levels of healthcare so they reach patients without delay.
Through pioneering national scientific meetings, driving Canadian-made consensus guidelines, promoting accredited medical education, and funding competitive research grants, Myeloma Canada is accelerating progress to improve the lives of people impacted by myeloma.